Italian Health minister Roberto Speranza said that, A plant in Italy owned by U.S. group Catalent will help produce the potential coronavirus vaccine being developed by drugmaker Johnson & Johnson,
Roberto Speranza said that “It is today’s news that the vaccine Johnson & Johnson is working on will also be completed here,” he said while during a visit to the site in Anagni, a town 70 km from Italian capital Rome.
The plan to produce the potential vaccine in Italy represents an expansion of an existing deal between the 2 American companies.
Your email address will not be published. Required fields are marked *